NeurAxis's robust sales growth and disciplined cost management have set the stage for achieving cash flow breakeven in 2026. Notably, recent investments from life science-focused funds have bolstered ...
A discussion with Campbell Rogers, MD, regarding advances in AI technology for prevention and management of coronary artery disease.
A Virginia Beach doctor, along with his practice, has recently agreed to pay $625,000 as part of of a civil fraud case.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback